QCM
AXSM icon

Quantinno Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Quantinno Capital Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.04M Buy
12,425
+928
+8% +$201K ﹤0.01% 1624
2026
Q1 		$1.94M Buy
11,497
+5,019
+77% +$867K ﹤0.01% 1639
2025
Q4 		$1.18M Buy
6,478
+3,636
+128% +$508K ﹤0.01% 1672
2025
Q3 		$345K Buy
2,842
+668
+31% +$75.2K ﹤0.01% 2339
2025
Q2 		$227K Buy
+2,174
New +$230K ﹤0.01% 2246

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Quantinno Capital Management's AXSM Position: Q2 2026 in Review

Quantinno Capital Management increased its Axsome Therapeutics (AXSM) stake by 8.1% in Q2 2026, buying an estimated $201K and bringing the position to 12,425 shares worth $3.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1624.

Quantinno Capital Management first reported a position in AXSM in Q2 2025 and has held it in 5 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Quantinno Capital Management held 12,425 shares of Axsome Therapeutics worth $3.04M as of Q2 2026.
  • Quantinno Capital Management bought 928 Axsome Therapeutics shares in Q2 2026, an estimated $201K.
  • Axsome Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1624 holding.
  • Quantinno Capital Management first reported a position in Axsome Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.